Related Experiment Video
Updated: Jan 25, 2026
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Time matters for metas: a systematic review and meta-analysis of ect vs ketamine for depression incorporating time
Stevan Nikolin1,2, Clara Massaneda-Tuneu3, Louise Brettell3,4
1Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, Australia. stevan.nikolin@unsw.edu.au.
Importance:
Comparing treatments for severe and medication-resistant depression is essential for guiding clinical decision-making.
Objective:
In this meta-analysis, we investigate the efficacy of electroconvulsive therapy (ECT) compared to ketamine for the treatment of major depressive disorder (MDD) and address the discrepant results of prior meta-analyses.
Data Sources:
We systematically searched PubMED (MEDLINE), Embase, and Cochrane Library databases for studies published up to 31 November 2024.
Study Selection:
Eligible studies met the following criteria: (1) participants diagnosed with major depression, (2) ECT and ketamine (administered via parenteral routes) treatment arms with comparable treatment durations and assessment periods, and (3) efficacy measured by standardized depression scales at a minimum of two time points.
Data Extraction And Synthesis:
The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two independent reviewers assessed study eligibility, evaluated risk of bias (Cochrane Risk of Bias 2 tool), and extracted data from all available time points. A mixed-effects meta-regression analysis incorporated time as a fixed effect - minimising issues arising from temporal discrepancies between studies - and study as a random effect.
Main Outcomes And Measures:
Efficacy was assessed by change in depression symptoms from baseline on a standardised measurement tool.
Results:
Seven studies (731 participants) out of 1220 identified articles were eligible for analysis. Depression scores were significantly lower at baseline in the ketamine group compared to ECT (SMD = -0·28; p = 0·018; 95% CI -0·51-·05). Meta-regression analysis, adjusted for baseline scores, revealed a significant effect of time for standardised mean differences (β = 0·018; p < 0·0001; 95% CI 0·009-0·026), indicating that ECT led to a faster rate of improvement of approximately 0·02 SMD per day, amounting to a predicted SMD = 0·59 (95% CI -0·26-1·43) over four weeks.
Conclusions And Relevance:
ECT resulted in a more rapid reduction of depressive symptoms, with a projected moderate efficacy advantage over ketamine by the end of a four-week course, within the established range for a clinically meaningful benefit.
More Related Videos
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
01:09Directing Effect of Substituents: meta-Directing Groups
01:13meta-Directing Deactivators: –NO2, –CN, –CHO, –CO2R, –COR, –CO2H
01:05Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
01:02Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...
01:22Generation Time
01:19Mixing Time